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310n Beam Applications (IBA), Belgium
4University of Tsukuba, Tsukuba, Ibaraki 305, Japan

Abstract
A silicon-on-insulator diode array with a sensitive depth
of 10 microns has been developed for microdosimetry in
proton therapy. The detector was coupled to a radiation-hard
charge sensitive amplifier with the probe assembly capable of
measuring an LET down to 1.2 keV/ym. The device has been
successfully tested at two proton therapy centers: The 230
MeV Northeastern Proton Therapy Center, Boston and the
250 MeV Proton Medical Research Center at Tsukuba, Japan.
The device offers much improved spatial resolution compared
with a proportional gas counter particularly in the critical
high dose region around the proton Bragg peak. Due to its
small cross-sectional area (0.04 cm2) measurements may also
be made in facilities with short high intensity beams.

I. INTRODUCTION
Silicon detectors during the last decade have found a wide
range of applications in radiation oncology. This has been
greatly assisted by the development of detector systems for
high energy physics (HEP) in which many advances have
been made in the areas of radiation hardness and low noise
multi-channel readout integrated systems.

ion therapy. The key advantage of proton therapy lies in the
local delivery of dose at high depths in tissue due to the
energy loss depth dose profile of high-energy protons in
matter (Bragg peak).
Protons interact with matter by continuous slowing down
as a result of Coulomb collisions with electrons and nuclei, by
Bremsstrahlung radiation loss, and by nuclear reactions. The
Coulomb interaction with electrons is the predominant
mechanism for energy loss and is typically described by the
electronic stopping power or Linear Energy Transfer (LET,
dE/dx) of the proton [ 5 ] . Radiation loss is negligible for the
energies of interest in proton therapy. However, nuclear
reactions have a significant effect on the proton beam
characteristics. The probability that protons will undergo a
nuclear interaction whilst traversing 1 gm/cm2 is around 1%
and after 20cm 1 in 4 protons will have suffered a nuclear
interaction. A NIST report by Seltzer [6] and summarized by
Miller [4] describes the interactions and products.
Approximately 21% of the energy lost in slowing down a 250
MeV proton beam in water is due to nonelastic nuclear
reactions. This fraction drops to around 4% for a 70 MeV
beam. Thus nuclear interactions affect the identity and energy
distribution of the secondary particles and decrease the
number of orimarv orotons in the beam.

In certain applications silicon based detectors offer
The radiobiological effectiveness of the beam is dependent
significant advantages particularly with regard to spatia1
on the particle types and their energy distribution. An
resolution. A new high spatial resolution silicon based
important characteristic of the beam is the LET spectrum of
microdosimeter has been developed using silicon-on-insulator
all primary and secondary particles responsible for the
(SOI) technology. Previous work characterized the sensitive
radiobiological
properties
of
beam.
Experimental
volume and radiation hardness of this detector [1] and its
microdosimetry attempts to quantify the LET spectrum by
performance in boron neutron capture therapy (BNCT) [2, 31.
measuring the energy deposited in a cell-sized volume. This
The development of an improved low noise may then be used to infer radiobiological properties of the
implementation of this device and testing at two proton beam relevant for treatment planning. Thus, microdosimetric
therapy facilities will be discussed. Experiments were measurements in a water phantom are important in high
conducted at the Proton Medical Research Center (PMRC) at energy proton therapy installations. Clearly, the relative
University of Tsukuba, KEK, Japan, using a 250 MeV proton biological effectiveness of the beam varies with depth. A 250
beam and at the Northeastem Proton Therapy Center MeV proton has an initial LET of 0.4 keV/um. This rises
(NPTC), Boston using a 230 MeV proton beam.
sharply in the Bragg peak region reaching a maximum value
Proton therapy is a very important radiation oncology of approximately 80 keV/pm within a few microns of the end
modality for the treatment of deep-seated tumors [4]. of the range. Microdosimetric measurements, at depths where
Currently, many HEP accelerator centers involved in medical protons enter the Bragg peak region, are particularly
programs have dedicated beams for proton therapy and heavy challenging due to the high spatial resolution required.

0018-9499/00$10.00
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11. MICRODOSIMETRY DEFINITIONS AND
SPECTRUM
PRESENTATION
The energy deposited in a microdosimeter is amplified
and recorded by a multi-channel analyzer to produce a
spectrum of the number of events recorded at different
energies. Experimental microdosimetry then introduces the
concept of lineal energy y (in keV/pm) which provides a
crude measure of particle LET. Lineal energy is defined as

Figure 2: SEM photograph of a portion of the IOxlOKm diode array.
(Note: Raised sections are aluminum tracks connecting contacts so
that all diodes are electrically in parallel. The width of the photo is
about 23pm.)
Microdosimetric studies of proton beams have been
performed by several investigators [7-121. Typically, a
spherical proportional counter containing a low pressure
tissue equivalent gas is used to obtain the spectrum of energy
deposition events [ 131. The millimeter resolution required in
the Bragg peak region is not achievable using such a counter
which normally has a diameter of 1-2 cm. The large size of
the counter also creates problems with pileup effects due to
simultaneous multiple events during high DC current
operation or when the proton beam consists of large currents
produced in nanosecond to microsecond pulses.
Measurements of microdosimetric spectra using a
proportional counter have been reported with count rates as
low as 350 countslsec still exhibiting pileup due to the large
size of the counter [IO]. Therefore, proton microdosimetry
requires small microdosimeters with high spatial resolution
(clmm) and small collection areas along with a short
collection time in the tens of nanosecond range. Analysis of
the pulse time structure of the beam current is important for
correct measurements of microdosimetry spectra.

where E is the energy imparted in the volume of interest by
an energy deposition event and is the mean chord length of
the volume [13]. Ionizing particles intercepting the volume
will produce a range of chord lengths and i is the mean of
the chord length distribution. Often is calculated assuming
the sensitive volume is immersed in a uniform isotropic
fluence of radiation with infinite range [13]. Given a-priori
information regarding the radiation field one may estimate a
most appropriate for the irradiation conditions. In our case,
I = 8.2 pm with the estimation discussed in section 1II.A
Thus, the energy deposited by each event is divided by the
mean chord length to give the lineal energy as per equation
(1). The dose distribution is then given by

D(Y) OC Y f W
(2)
where fb) is the lineal energy probability distribution
calculated from the number of events in the lineal energy
range interval dy and D b ) is the dose probability density
distribution [ 131. Note that standard microdosimetry
nomenclature presents D(y) as d(y) but we use the capital
form to improve readability and avoid confusing dy and db).
The dose distribution relationship simply reflects the fact that
higher lineal energies deposit a higher dose. By definition,
the distribution Db) is normalized to unity:

We are interested in quite a wide range of lineal energies
from lkeV/pm to several hundred keV/pm. In this range the
relative biological effectiveness begins to increase above
unity. Due to the wide lineal energy range, microdosimetric
spectra are traditionally presented in a log-linear format,
which requires further scaling to preserve the dose to area
correspondence. In summary, all microdosimetric spectra are
presented in the standard yD(Y)m yyb) versus log&) format.
The ordinate is displayed as yD(v) on a linear-log plot since

jD(Y)dY = ln(lO)jYD(Y)d(logY)

(4)
and this integral is proportional to the dose deposited in the
interval dy. Presented in this way, equal areas under different
regions of the function yD(Y) correspond to equal doses.
To convert to tissue equivalent (TE) microdosimetric
spectra the f of the silicon device is simply scaled by a factor
of 1/0.63. A previous paper by Bradley [ 141 has addressed the
issue of tissue equivalency of silicon based microdosimetric
measurements for BNCT [2, 31. The results are also
applicable for energy deposition through coulomb interactions
by higher energy protons. It was demonstrated [ 141 that under
appropriate geometrical scaling (dimensions multiplied by
1/0.63) silicon detectors with well known geometry will
record energy deposition spectra representative of tissue cells
of equivalent shape. Note, that the study neglected nuclear
reactions in the silicon since the incident charged particles,
particularly protons, will be much more frequent. In this
paper, with an emphasis on device operation, we present all
results based on the silicon mean chord length without TE
correction.

111. METHODS

A . New Silicon Microdosimeter
The silicon microdosimeter consists of a SO1 diode array
test structure fabricated by Fujitsu Research Laboratories
Ltd.[ 151. The application requires:
An accurately defined sensitive volume (region of charge
collection). Minimization of charge collection complexity
in particular diffusion and funneling effects.

An array of identical diodes to improve collection
statistics.
Diode structure sizes of the order of a few microns to
simulate biological cells with typical cell diameters of 1015pm.
Capable of measuring an LET down to about 1 keV/pm.
Above this value of LET the radiobiological effectiveness
begins to rise above 1.
An ideal silicon based microdosimeter collects charge in a
reverse-biased p-n junction diode via drift driven separation
of electron hole pairs in the depletion region. In reality,
charge collection is complicated by additional charge

collection via diffusion from outside of the depletion region.
By using SO1 structures, we preclude any charge collection
from beneath the SO1 layer due to the underlying insulating
layer of SOz. Such a design creates a sensitive volume of
well-defined depth.
The SO1 diode test structures were fabricated on bonded
SO1 wafers with thickness 2, 5, and 10 pm. In addition, a
bulk device (no SOI) was fabricated. Several diode array
structures are available on each device. For this study, the 10
pm SO1 device was used to provide a large sensitive volume
and best possible signal to noise ratio. The array consisted of
120x40=4800 diodes with each diode having a junction size
of lOxlOpm. The total size of each diode cell was 3Ox3Opm
giving an array area of 0.044 cm2. Note that all diodes in a
given array are connected in parallel. The n+ and p+ silicon
layers with depths 0.2 and 0.5 pm were constructed by
arsenic and boron implantations at 30keV and 5~10'~cm-*.
The impurity concentration of the P type silicon was
1 . 5 ~ 1 0 ' ~ c mThe
- ~ . device is packaged in a 28 Pin DIL
ceramic carrier. Figure 1 shows the over-layer and detailed
device cross-section whilst Figure 2 is a SEM photograph of a
portion of the small array.
The sensitive volume of the device and its radiation
hardness were determined by alpha spectroscopy and ionmicrobeam experiments using methods outlined in previous
work by us [l]. The device bias was set to 1OV so that the
depletion depth is approximately 3 pm. Hence the 10 pm SO1
is not fully depleted and charge collection occurs via diffusion
as well as drift processes. For the 10 pm device, the charge
collection efficiency was found to vary from about 0.79 in
regions most distant from a diode junction to 0.86 in the
center of a junction where drift collection is strongest. This
relatively small variation is a result of the large minority
carrier diffusion length (61 pm) in comparison to the cell
dimensions (30x30~1
Opm). Therefore, the collection
efficiency may be reasonably approximated by a constant
value of 0.82.
Microdosimetric spectra require an estimate of the
detectors mean chord length 7 . An accurate value of 7 may
be obtained via Monte-Carlo simulation methods which
transport the protons and other charged particles through the
experimental setup and determine the path length traversed
through the device. However, a reasonable first order
approximation assumes that the beam is largely normal to the
8.2pm.
diode surface in which case we may approximate
Two different probe assemblies are used in this work
corresponding to different stages in the project development:

-

Prototype
_ _ assembly #1: This probe was the first
assembly constructed and consists of the microdosimeter
package inserted into a machined Lucite holder with a 1 m
coaxial cable connecting the detector to a Canberra 2003T
charge sensitive preamplifier (CSA) as shown in Figure 3.
Noise was minimized by encapsulating the entire
microdosimeter probe in an aluminum foil shielding which
was then connected to the coaxial cable ground. This also
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ensured that the chip did not receive any light, which
generates significant noise via surface photo-generation.
An 8-meter coaxial cable links the preamplifier to a
Canberra 2024 Fast Spectroscopy amplifier. The output of
this amplifier is a voltage pulse whose amplitude is
proportional to the energy deposited in the sensitive volume
of the microdosimeter. Note that the microdosimeter collects
charge generated by the traversal of an ion through the
device’s sensitive volume. The charge collected is
proportional to the energy deposited, as it requires 3.6 eV to
generate an electron hole pair in silicon. The pulse height
from each event is digitized and stored using a PC based
Multi-Channel Analyzer (MCA).

Prototype assembly #2: The noise performance of the
first prototype could be significantly improved by removing
the IOOpF capacitance added by the detector to CSA cable
and improving shielding to gain immunity to external
electromagnetic fields (particularly RF interference). The
second prototype assembly, based on a printed circuit board
design, uses an AMPTEK A250 radiation-hard CSA in close
proximity to the detector. All components were selected
specifically to minimize noise based on our detector
characteristics. A system view of the low noise prototype is
shown in Figure 4.

A two-point calibration giving the gain and offset of this
system was performed using a polonium-210 alpha
spectroscopy source with alpha peak energy of 5.301 MeV
and an Americium-241 alpha-gamma source. The 60 keV
gamma peak of the Am-241 source was used as a low energy
reference point to ensure a good estimation of the calibration
offset. The diode array was replaced by a silicon ion
implanted detector of similar capacitance, which collects
charge corresponding to the total energy of the alpha particle.
Unlike a proportional counter, the silicon diode array does
not require a high voltage supply. The supply voltage used in
these experiments was 10 V reverse bias.

Fet Modcl

Figure 5 : Noise model of microdosimeter and charge sensitive prcamplifier

I

Proton
Canberra 20031

Multi-Channel Analyzer

Analyser

Probe Assembly

Equipment Inside Treatment Room A q u l p m e n t outside Treatment Room

In order to optimize the noise performance of the detector
a noise model of the system was developed as depicted in
Figure 5. The model considers the primary noise sources as
the bias resistor Rb and feedback resistor Rf thermal noise; the
detector current Id shot noise; the thermal noise associated
with the input transistor channel resistance and the l/f noise
of the JFET.
Following standard noise analysis methods such as
presented by Delaney and Finch [I61 or Radeka [17] we
arrive at the following expression for the Equivalent Noise
Charge (ENC)

Figure 3: Experimental setup for microdosimetry measurements at
PMRC (Tsukuba) using prototype assembly #I (original assembly)

Jam
le Water Proof Case
Aluminium Shield
Equipment inside Trealment Room A q u i p m e n t outalde Treatment Room

Figure 4: Experimental setup for microdosimetry measurements at
NPTC (Boston) using prototype assembly #2 (low noise)

Cd = detector
where l/RT = l/Rb+l/Rf and Ci,,=Cd+Cg+Cstray,
capacitance, C, = JFET gate capacitance, C,,,, = stray input
capacitance, T = shaping time constant of spectroscopy
amplifier, Kf = l/f noise coefficient, k = Boltzmann’s
constant and T = temperature (300 K).
The calculation assumes that the feedback time constant
(R&J and input time constant (Rb Ci,,) are much greater than
T and that the buffer and spectroscopy amplifier contribute
negligible noise. The spectroscopy amplifier frequency
response is modeled as a simple RC-CR filter
c
u
t Kn

~~i~

u)z
1+ w 2 z 2
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Typical values for these components and the relative noise
contributions are given in Table 1. Therefore minimizing the
ENC requires selecting a high g, FET with small gate
capacitance and gate current and maximizing Rb and Rf . We
select a bias voltage of between 10 and 20V since in this
range the capacitance is reduced without excessive reverse
bias current. The 2SK152 FET was selected for its excellent
gJC, ratio. Due to the presence of high count rates the
shaping time was normally set to 0.25 ps.
Actual values of noise measured using an Ortec 414 pulsar
are 4.7 keV compared with the theoretical estimation of 4.44
keV. The difference may be attributable to additional leakage
current on the PCB board, variation in transistor
specifications and imperfect shielding of the detector from
external noise sources. Given that lower level discriminator
settings are typically twice the FWHM we may expect to be
able to measure down to around 1.1 keV/pm with this device.
The optimum value of noise would involve paralleling several
FETs such that the detector and input capacitance matched
and also adjusting the shaping time to 0.5 ps. A noise level of
around 300 e rms or 2.5 keV could then be obtained.
Calibration of this low noise prototype is performed as per the
older prototype discussed earlier.
Table 1.
Relative contribution of noise components in microdosimeter desi n
1 Relevant Values
1 Noise
1 Noise (z = 0.25 ps)
Source
Electrons (RMS)
Rb

Rf

100 MR
300 Mi2

Id

I5nA

JFET
(2SK152)
Other

I g,=20mS

I K=10-27J,

77

45
I 240
Cg=6pF,
I 254 (channel)
- -

19

(lif)

protons/pulse are transported to the medical beam line. Then
the beam is momentum filtered and shaped for a 10 x10 cm2
field. Thus, the beam intensity is around 4
proton/pulse/device which is much higher than at NPTC.
This beam presents a difficult experimental challenge even
when using the small area of the silicon based
microdosimeter. Clearly, the high luminosity of this beam
prevents the use of a proportional gas counter for
microdosimetry due to strong pile up effects. Note that
reducing the beam current does not reduce pile up effects
since it usually involves a reduction in the frequency of pulses
rather than the number of protons per pulse.
However, to reduce the protons per pulse one can control
the momentum slit width (X) and vertical slit width (Y)
which are typically set to 150 and 30 mm respectively.

B. Experimental Setup
The microdosimeter was placed in a 15~15x30cm3 Lucite
phantom constructed of 2.5 cm blocks. Such a construction
allowed the placement of the detector at different positions
along the beam line axis. To avoid pile-up and ensure a
constant energy the momentum slit was fixed at X = 3 mm
whilst the vertical slit was varied from Y = 30 to 2”.
Microdosimetric spectra at a depth of 17.5 cm were recorded
at various values of vertical slit width to determine the
settings required to remove pile-up effects. The acquisition
time for the measurements was 600 seconds. Measurements at
various depths in the Lucite phantom were then performed
having found the beam setup which eliminated pile-up. The
integral depth-dose was measured by a MOSFET detector.

C. Results: Microdosimetric Spectra

The depth-dose curve obtained using a MOSFET detector
placed at various depths in the Lucite phantom are shown in
Figure 6. The advantageous characteristic of a MOSFET
I 524 erms=4.44 keV
Total
dosimeter is the extremely small dosimetric volume (-lpm)
defined by the gate oxide thickness [19, 201. High spatial
IV. EXPERIMENT
AT PMRC-TSUKUBA
resolution measurements are achievable in the Bragg peak
regions. However, the response of the MOSFET is dependent
on the particle LET and angle with respect to the oxide
A . Proton Therapy Facility
electric field. Further investigation and comparison studies
The proton therapy facility at PMRC uses the KEK 500
should be performed to compare the depth-dose derived from
MeV booster synchrotron as a beam source [ 181. This source
ionization chambers versus MOSFETs.
was originally designed for HEP experiments and since the
The microdosimetric spectra obtained as a function of
energy and intensity are too high for medical applications, the
beam energy is degraded down to 250 MeV using carbon depth in Lucite are shown in Figure 7. The small peaks from
based degraders. Additional filters reduced this to 200 MeV 30-100 keV/pm are due to statistical uncertainties. The
for these experiments. In contrast to the NPTC facility, this general shift in the spectrum to higher lineal energies as
synchrotron produces 50 ns pulses with an initial 2x109 depth increases from 14 cm to 17.5 cm is evident. The
protons per pulse. The time interval between pulses is about 1 MOSFET depth-dose data indicates that at around 17.5 cm
second in parasitic beam mode and 0.05 seconds in full beam many of the protons will be approaching the end of their
mode. Note that the protons/pulse is the same for both range. In this region, the protons have a higher LET, and
parasitic mode and full beam mode. The full beam mode is therefore higher lineal energy, as they approach the Bragg
used for patient treatment and provides a dose rate of peak. This behavior is in agreement with results obtained at
NPTC and by Coutrakon [ 111 using a proportional counter.
approximately 200 cGy/min.
The data obtained using the prototype assembly #1
The initial beam intensity is reduced by the carbon
degrader followed by a collimator such that around lo4 exhibited significant environmental noise problems

Iz

=

0.25 ps,
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particularly when the beam RF was turned on. It is expected
that the second prototype with its significantly improved
shielding will avoid such difficulties. The lineal energy could
not be obtained below 8 keV/pm due to the high noise levels.
This was the motivation for development of the low noise
prototype. Despite the limited clinical utility of the
incomplete spectrum, we may still verify the capability of the
device in terms of high count-rate performance.
The vertical slit was adjusted down to 2 mm from the
normal value of 30 mm in order to avoid pile-up. Figure 8
shows a comparison of microdosimetric spectrum obtained
under Parasitic-Beam and Full-Beam modes at PMRC with
different vertical slit widths (depth in Lucite phantom = 17.9
cm). This example shows significant pile-up effects using the
Parasitic Beam despite its much lower total intensity. To
avoid pile-up in either mode the beam requires a vertical slit
width of 2 nun in order to reduce the number of protons/spill.
The spectra of Figure 7 obtained at various depths used such
a slit arrangement. The results indicate that the low noise
prototype applied to similar beam conditions should be
capable of measuring the microdosimetric spectrum down to
1.2 keV/pm without significant pile-up complications.
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V. EXPERIMENT
AT NPTC-BOSTON
A. Proton Therapy Facility
The new proton therapy facility at NPTC utilizes a 230
MeV beam extracted from an isochronous cyclotron [21, 221.
The accelerator was built by Ion Beam Applications (IBA),
Belgium and has a maximum current of 1.5 pA which is
hardware limited to 300 nA in order to limit the maximum
dose rate to the patient. After extraction from the cyclotron
the
beam passes through the Energy Selection System (ESS)
0
5
10
15
20
designed to give a beam of any energy between 70 and 230
Depth in Perspex (cm)
Figure 6: Bragg peak of 200MeV proton beam (PMRC-Tsukuba) MeV with a user defined momentum width and emittance.
derived by MOSFET detector in Lucite phantom. Relative dose is The ESS uses a rapidly adjustable rotating variable thickness
of graphite. Slits are provided just after the energy degrader
the dose normalized to maximum dose at depth of 17.4 cm.
to reduce the beam divergence to AE/E<+l%. The facility
uses a range modulator filter to create the desired spread in
U
1.
the proton Bragg peak. A double scattering system using a
._
fixed scatterer and a second non-uniform thickness scatterer
o.8
produce a beam with uniform intensity in the lateral profile
- 14~m
0.6 :
over a 10x10 cm2 field size.

w

:

$ i
2

17.m .

0" 0.4
2 . .
9.0.2

18.b :

L

LinealEnergy keV u m

Figure 7: Microdosimetric spectra of 200MeV proton beam (PMRCTsukuba) at various depths in a Lucite phantom. Range of proton is
approximately 18cm.

The NPTC cyclotron operates in continuous wave mode
using a 106 MHz RF frequency. Acceleration of protons
occurs within 10-15 degrees of the RF wave. The time
structure of the beam is therefore semi-DC with a duty-cycle
of about 10% (30deg/330deg). A typical treatment beam is 2
nA equivalent to 1.25 x 10" protondsecond. So in a single
RF cycle of 9.4 ns there are 118 protons spread over 0.8 ns.
For the case of a 10x10 cm2 field size (obtained using a
double scattering method) we can expect 1.2 p/cm2/cycle.
Under these conditions, a microdosimeter should have a small
cross-sectional area and fast collection time.
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120

B. Experimental Setup

s

The microdosimeter selected has an active cross-sectional
area of 0.044 cm2. The minimum amplifier shaping time
available was 0.25 ps and the Ortec pile-up reject system was
employed to eliminate pile-up signals. Note that decreasing
the amplifier shaping time further would increase noise to
unacceptable levels. In order to maintain a reasonable deadtime (less than about 20%) we require less than 1 proton per
1.25 ps striking the detector. Such a requirement may be
fulfilled using a beam current of 0.25 nA in which case we
expect 0.7 p/ps/(device area). In practice, higher beam
currents (up to 1 nA) could be employed without excessive
dead-time and distortion of the spectra due to pile-up events.
The quick calculations performed above do not include losses
of beam current due to scattering outside of the beam field.
The microdosimeter was placed in a Scandtronix water
tank (Model RFA-300 Plus) which enabled rapid remote
adjustment of the detector position. The detector position was
aligned with the center of the beam and microdosimetric
spectra were recorded at various distances from the beam side
wall of the tank. At each depth, spectra were recorded using
two different gains to provide adequate dynamic range in the
final merged spectrum. Initially the beam current was
adjusted to ensure that the spectra were not corrupted by pileup events. Furthermore, during measurements, the signal
prior to the MCA was monitored continuously with an
oscilloscope to ensure the average interval between pulses
was reasonable and no pileup was present. The typical
acquisition time was 600 seconds.
In addition, measurements of the depth-dose profile in the
water tank were performed using a Markus ionization
chamber. Measurements were made every 0.3 cm for the
range 0-30 cm along the beam axis.
The proton beam was setup with the energy degrader in
pass though position and the ESS configured to provide the
full cyclotron energy of 230.5 MeV with an AE/E of 0.18%.
The cyclotron energy is attenuated by the items identified in
Table 2 so that the final energy (calculated using SRIM code
[23]) of protons entering the water is 191.5 MeV.

Item

Table 2.
Beam items in nozzle of NPTC
Material
Thick
Eout
(cm)
(MeV

Elost
(MeV

Ionchambers I Water Eq I 0.304 I 197.0 I 1.4
Phantom wall I Lucite
I 191.5 I 5.5
11
Water Eq: means that the effective thickness is specified in water
equivalent terms. The beam spreading filter is made of lead and
Lexan.
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Figure 9: Depth-Dose curve for the NPTC 191.5 MeV proton beam
in water. Relative dose is defined as Dose(Markus)/Maximum
Dose(Markus). The maximum dose is at 23.2 cm and the relative
dose = 1 at this point. The depths at which microdosimetric
measurements are made are shown.

C. Results: Microdosimetric Spectra
The microdosimetric spectra obtained as a function of
depth at NPTC are shown in Figure 10. One first notes the
significantly improved noise performance of the low noise
prototype in comparison to measurements made at PMRC.
Measurements were obtained down to the noise level of about
1.2 keV/pm. The depth-dose curve obtained using the Markus
chamber and the microdosimeter measurement positions are
shown in Figure 9. At depths less than 20cm, the large dose
contribution from low lineal energy events is due to
significant high energy proton and gamma contributions
which both have an LET below 2 keV/pm. As we approach
the Bragg peak, the LET of the protons rises as seen by the
increase in the mean lineal energy and the shift of the spectra
to higher lineal energies at depths between 20-26 cm. These
effects were also observed using a proportional counter at the
Loma Linda proton beam by Coutrakon et.al. [l 11 This shift
is not due to pileup effects since, firstly, the signal was
continuously monitored with an oscilloscope and, secondly,
the count rate is lower at higher depths due to beam
spreading.
Note the step decline in the microdosimetric spectra at
around the maximum LET of protons of 78 keV/pm. Dose
contributions are evident at lineal energies above the
maximum proton LET due to nuclear reaction products such
as alpha particles and heavy ion recoils. However, the relative
number of such events is much smaller than the proton events
hence the step change above the maximum proton LET. As
we exceed the maximum range of the protons, the higher
lineal energy components contribute a relatively higher
proportion of dose. At 30cm, well past the primary proton
range, the spectrum is comprised totally of neutron reaction
products including recoil protons, alpha particles and heavy
ion recoils. The neutron reaction products tend to have a
large proportion of dose at higher lineal energies.
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V I . CONCILJSION
These measurements provide valuable information for
radiobiological studies of the varying effectiveness of the
beam as a function of depth. Future work may be directed
towards the analysis of beam relative biological effectiveness
such as performed at Loma Linda by Coutrakon et. a1 [ 1 11 at
a higher spatial resolution than previously attempted.
In general, pile up and perturbation effects were avoided
due to the small area (0.04 mi2) of the total pixel array.
Pileup did occur for experiments at PMRC when the vertical
momentum slit width was greater than 2 mm. Under these
conditions, an even smaller area detector is required. The
detector was coupled to a radiation-hard charge sensitive
amplifier with the probe assembly capable of measuring an
LET down to 1.2 keV/pm. The device offers much improved
spatial resolution compared with a proportional gas counter
particularly in the critical high dose region around the proton
Bragg peak.
We have demonstrated a new approach to microdosimetry
in radiation oncology using a silicon SO1 p-n junction array
applied to proton therapy beams. Low noise, small size and
good radiation hardness facilitate the application of this
device in radiation oncology.
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